SCHEMBL543039

SCHEMBL543039

FC(F)(F)c1cccc([CH]Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.55
FBP1 P09467 1/20 0.51
MGLL Q99685 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
P4HB P07237 2/20 0.45
TTR P02766 1/20 0.45
PIM1 P11309 1/20 0.45
CISD1 Q9NZ45 1/20 0.45
PIM2 Q9P1W9 1/20 0.45
LMNA P02545 1/20 0.45
HSP90AA1 P07900 1/20 0.45
PKM P14618 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27945788 0.83 NFE2L2 (0.61) NFE2L2FBP1TSHRMAPK1MEN1
SCHEMBL3237563 0.82 NFE2L2 (0.58) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL5537772 0.80 NFE2L2 (0.56) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL543252 0.80 NFE2L2 (0.56) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL15741569 0.78 NFE2L2 (0.55) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL127539 0.78 NFE2L2 (0.55) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL13790316 0.78 NFE2L2 (0.82) NFE2L2FBP1TSHRMAPK1MEN1
SCHEMBL543469 0.78 NFE2L2 (0.59) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL216268 0.78 NFE2L2 (0.55) NFE2L2FBP1MGLLTSHRMAPK1
SCHEMBL67201 0.78 FBP1 (0.56) NFE2L2FBP1TSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102203060-B 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists HOFFMANN LA ROCHE 2014-09-24 CN disclosed
CN-101374817-B Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein CETP MITSUBISHI TANABE PHARMA CORP 2014-07-30 CN disclosed
CN-103497188-A Compounds modulating c-fms and/or c-kit activity and uses therefor PLEXXIKON INC 2014-01-08 CN disclosed
CN-101605787-B Compounds that modulate c-fms and/or c-kit activity and uses thereof PLEXXIKON INC 2013-11-13 CN disclosed
CN-103172562-A Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein CETP TANABE SEIYAKU CO 2013-06-26 CN disclosed
CN-101910138-B Herbicidal compounds SYNGENTA LTD 2013-06-26 CN disclosed
CN-101959516-B Combination therapy comprising quinoxaline PI3K alpha inhibitors for the treatment of cancer EXELIXIS INC 2013-05-08 CN disclosed
EP-2414330-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS Merck Patent GmbH (DE) 2012-02-08 EP disclosed
WO-2010115491-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2010-10-14 WO disclosed